Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Stock analysts at HC Wainwright cut their Q3 2026 earnings per share estimates for Compass Therapeutics in a report released on Thursday, August 6th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings of ($0.15) per share for the quarter, down from their […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | HC Wainwright Issues Optimistic Estimate for CNTX Earnings | 0 | 12.95 | 10-08-2026 |
| 2 | What is HC Wainwright’s Forecast for Biodesix Q3 Earnings? | 0 | 12.55 | 10-08-2026 |
| 3 | Q3 EPS Estimates for CG Oncology Lowered by HC Wainwright | 0 | 11.48 | 10-08-2026 |
| 4 | What is HC Wainwright’s Estimate for PTGX FY2026 Earnings? | 0 | 13.4 | 10-08-2026 |
| 5 | HC Wainwright Has Positive Forecast for ARQT Q3 Earnings | 0 | 11.13 | 10-08-2026 |
| 6 | HC Wainwright Has Optimistic Outlook of TNYA FY2026 Earnings | 0 | 11.9 | 10-08-2026 |
| 7 | Brokers Offer Predictions for Centrus Energy FY2026 Earnings | 0 | 14.22 | 10-08-2026 |
| 8 | HC Wainwright Expects Reduced Earnings for Alto Ingredients | 0 | 10.44 | 10-08-2026 |
| 9 | HC Wainwright Issues Pessimistic Outlook for SABS Earnings | 0 | 12.58 | 10-08-2026 |
| 10 | HC Wainwright Issues Pessimistic Estimate for ARWR Earnings | 0 | 13.33 | 10-08-2026 |